R&D 

Copyright(c)2017 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 243 Gong Ye Bei Road, Jinan, Shandong 250100, CHINA

PRODUCTS

MANUFACTURING

NEWS

CONTACT US

ABOUT US

Qilu Launches Generic Aloxi® Injection in the US

Classification:
Company news
Author:
QILU PHARMACEUTICAL
Source:
QILU PHARMACEUTICAL
Release time:
2018/09/19 17:03
Page view
[Abstract]:
Sep.19,2018—QiluPharmaceutical todayannouncedtheU.S.approvalandlaunchofPalonosetronHClInjection(2.5mg/5ml),agenericversionofAloxi® ,whichmakesthefirstDay181launchedproductsforQiluinUS.Uptonow,Qiluhasl

Sep. 19, 2018—Qilu Pharmaceutical today announced the U.S. approval and launch of Palonosetron HCl Injection (2.5mg/5ml), a generic version of Aloxi® , which makes the first Day 181 launched product for Qilu in US. Up to now, Qilu has launched ten products in US and among them, eight products are the injectables. 

NEWS